The Immune Response Modifiers Imiquimod and R-848 Are Potent Activators of B Lymphocytes
- 1 July 2000
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 203 (1) , 55-65
- https://doi.org/10.1006/cimm.2000.1673
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- Imiquimod 5% cream (Aldara™)Expert Opinion on Investigational Drugs, 1998
- The collectins in innate immunityCurrent Opinion in Immunology, 1996
- Immunomodulating and antiviral activities of the imidazoquinoline S-28463Antiviral Research, 1995
- Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609Journal of Interferon & Cytokine Research, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Enhancement of Immunostimulatory Activity by Dual Substitution of C8-Substituted Guanine RibonucleosidesJournal of Immunotherapy, 1995
- Muramyl peptides: Immunomodulators, sleep factors, and vitaminsMedicinal Research Reviews, 1984
- Modulation of the immune system by synthetic polynucleotidesSpringer Seminars in Immunopathology, 1979